Evidence map›Paper›PMID 38347193›Full record

ArticleNature2024

Publisher Correction: Hypoblast from human pluripotent stem cells regulates epiblast development.

Takumi Okubo, Nicolas Rivron, Mio Kabata, Hideki Masaki, Keiko Kishimoto, Katsunori Semi, May Nakajima-Koyama, Haruko Kunitomi, Belinda Kaswandy, Hideyuki Sato and 6 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Takumi OkuboCenter for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0009-0009-6627-8383
Nicolas RivronInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna BioCenter (VBC), Vienna, Austria.ORCID http://orcid.org/0000-0003-1590-5964
Mio KabataCenter for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
Hideki MasakiInstitute of Medical Science, University of Tokyo, Tokyo, Japan.
Keiko KishimotoCentral Institute for Experimental Animals, Kawasaki, Japan.
Katsunori SemiCenter for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
May Nakajima-KoyamaCenter for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
Haruko KunitomiCenter for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0000-0003-3045-337X
Belinda KaswandyCenter for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
Hideyuki SatoInstitute of Medical Science, University of Tokyo, Tokyo, Japan.
Hiromitsu NakauchiInstitute of Medical Science, University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0002-9841-6973
Knut WoltjenCenter for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0000-0003-2293-1183
Mitinori SaitouCenter for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
Erika SasakiCentral Institute for Experimental Animals, Kawasaki, Japan.ORCID http://orcid.org/0000-0002-0415-5400
Takuya YamamotoCenter for iPS Cell Research and Application, Kyoto University, Kyoto, Japan. takuya@cira.kyoto-u.ac.jp.ORCID http://orcid.org/0000-0002-0022-3947
Yasuhiro TakashimaCenter for iPS Cell Research and Application, Kyoto University, Kyoto, Japan. y.takashima@cira.kyoto-u.ac.jp.ORCID http://orcid.org/0000-0003-0126-7260

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38347193
PMCPMC10901728

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.